Belite Bio, Inc. (BLTE)

141.00 -9.24 (-6.15%) USD  |  NASDAQ  |  Dec 12, 16:00
141.32 +0.32 (+0.23%) After-Hours: 20:00
More

Belite Bio Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
IDEAYA Biosciences, Inc. Upgrade
Janux Therapeutics, Inc. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade